Soligenix Inc SNGX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.9745quote price arrow up+0.0045 (+0.46%)
Volume
130,049
52 week range
0.85 - 2.80

...

Loading . . .
  • Open0.9637
  • Day High0.98
  • Day Low0.953
  • Prev Close0.97
  • 52 Week High2.80
  • 52 Week High Date12/17/20
  • 52 Week Low0.85
  • 52 Week Low Date05/13/21

Key Stats

  • Market Cap39.06M
  • Shares Out40.08M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-23.87

KEY STATS

  • Open0.9637
  • Day High0.98
  • Day Low0.953
  • Prev Close0.97
  • 52 Week High2.80
  • 52 Week High Date12/17/20
  • 52 Week Low0.85
  • 52 Week Low Date05/13/21
  • Market Cap39.06M
  • Shares Out40.08M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-23.87

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-2.36
  • Fwd P/E (NTM)-2.71
  • EBITDA (MRQ)-12.293M
  • ROE (MRQ)-119.71%
  • Revenue (MRQ)1.58M
  • Gross Margin (MRQ)29.62%
  • Net Margin (MRQ)-787.98%
  • Debt To Equity (MRQ)59.14%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Soligenix Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two business segments: Specialized BioTherapeutics and Public Health Solution. Soligenix’s Specialized BioTherapeutics business segment is developing a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of...
Christopher Schaber Ph.D.
Chairman
Jonathan Guarino CPA
Chief Financial Officer
Address
29 Emmons Dr Ste B10
Princeton, NJ
08540-5950
United States

Top Peers

SYMBOLLASTCHG%CHG
BFNH
BioForce Nanosciences Holdings Inc
0.95-0.06-5.9406%
BBI
Brickell Biotech Inc
0.6584-0.0211-3.1052%
CANF
Can Fite Biopharma Ltd
2.07-0.02-0.96%
XBIO
Xenetic Biosciences Inc
3.52-0.94-21.08%
GOVX
GeoVax Labs Inc
4.33-0.05-1.14%